Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease

Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease

Graft-versus-host disease (GVHD) is a common complication in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). GVHD is characterized as either acute or chronic based on symptomatology and histopathological findings. Despite advancements in disease-targeting therapeutics,...

Full description

Bibliographic Details
Main Authors: Yijun Cai, Amir Ali, Elan Filler, Rua Bayati, Tanjia Toma, Omar Zaki, George Yaghmour, Abdullah Ladha, Karrune Woan, Eric Tam, Preet M. Chaudhary
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
graft-versus-host disease
steroid-refractory
hepatic variant
allogeneic hematopoietic stem cell transplantation
ruxolitinib
pulse cyclophosphamide
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1329893/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1329893/full

Similar Items